Pancreatic Cancer Research

ResearcherUniversity of LouisvilleNo recent work listed

Yan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9403-9533; OpenAlex author ID A5100380400. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2022-006221↗
  2. Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cti2.1430↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert C.G. Martin · 2 shared papers, 2022–2023 · strength 0.28
  2. Robert A Mitchell · 1 shared paper, 2023 · strength 0.15
  3. Matthew R. Woeste · 1 shared paper, 2023 · strength 0.15
  4. Chuanlin Ding · 1 shared paper, 2023 · strength 0.15
  5. Anne E. Geller · 1 shared paper, 2023 · strength 0.15
  6. Jun Yan · 1 shared paper, 2023 · strength 0.15
  7. Young Ki Hong · 1 shared paper, 2022 · strength 0.13
  8. Harshul Pandit · 1 shared paper, 2022 · strength 0.13
  9. Neal Bhutiani · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.